Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistance

Author:

Nouri Mannan12,Caradec Josselin12,Lubik Amy Anne12,Li Na1,Hollier Brett G.3,Takhar Mandeep4,Altimirano-Dimas Manuel1,Chen Mengqian5,Roshan-Moniri Mani1,Butler Miriam1,Lehman Melanie3,Bishop Jennifer1,Truong Sarah1,Huang Shih-Chieh1,Cochrane Dawn6,Cox Michael12,Collins Colin12,Gleave Martin12,Erho Nicholas47,Alshalafa Mohamed4,Davicioni Elai47,Nelson Colleen13,Gregory-Evans Sheryl8,Karnes R. Jeffrey9,Jenkins Robert B.10,Klein Eric A.11,Buttyan Ralph12

Affiliation:

1. Vancouver Prostate Centre, Vancouver, Canada

2. Department of Urologic Sciences, University of British Columbia, Vancouver, Canada

3. Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia

4. GenomeDX Biosciences, Vancouver, Canada

5. Drug Discovery & Biomedical Sciences, South Carolina College of Pharmacy, Columbia, South Carolina, USA

6. Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, Canada

7. GenomeDX Biosciences, San Diego, California, USA

8. Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, Canada

9. Department of Urology, Mayo Clinic, Rochester, Minnesota, USA

10. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA

11. Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA

Publisher

Impact Journals, LLC

Subject

Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3